216 related articles for article (PubMed ID: 27916281)
41. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
42. Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis.
Chen P; Zuo H; Xiong H; Kolar MJ; Chu Q; Saghatelian A; Siegwart DJ; Wan Y
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):580-585. PubMed ID: 28049847
[TBL] [Abstract][Full Text] [Related]
43. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
Tot T
Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
[TBL] [Abstract][Full Text] [Related]
44. Variations in stromal signatures in breast and colorectal cancer metastases.
Webster JA; Beck AH; Sharma M; Espinosa I; Weigelt B; Schreuder M; Montgomery KD; Jensen KC; van de Rijn M; West R
J Pathol; 2010 Oct; 222(2):158-65. PubMed ID: 20593409
[TBL] [Abstract][Full Text] [Related]
45. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
[TBL] [Abstract][Full Text] [Related]
46. PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.
Gärtner S; Gunesch A; Knyazeva T; Wolf P; Högel B; Eiermann W; Ullrich A; Knyazev P; Ataseven B
PLoS One; 2014; 9(1):e84472. PubMed ID: 24409301
[TBL] [Abstract][Full Text] [Related]
47. Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells.
Chung ST; Geerts D; Roseman K; Renaud A; Connelly L
Mol Cancer; 2017 Feb; 16(1):27. PubMed ID: 28143606
[TBL] [Abstract][Full Text] [Related]
48. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer.
Kundu M; Butti R; Panda VK; Malhotra D; Das S; Mitra T; Kapse P; Gosavi SW; Kundu GC
Mol Cancer; 2024 May; 23(1):92. PubMed ID: 38715072
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
[TBL] [Abstract][Full Text] [Related]
50. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
51. GPER is involved in the functional liaison between breast tumor cells and cancer-associated fibroblasts (CAFs).
Lappano R; Maggiolini M
J Steroid Biochem Mol Biol; 2018 Feb; 176():49-56. PubMed ID: 28249728
[TBL] [Abstract][Full Text] [Related]
52. Tumor-associated macrophages (TAMs): clinical-pathological parameters in squamous cell carcinomas of the lower lip.
Lúcio PS; Ribeiro DC; Aguiar MC; Alves PM; Nonaka CF; Godoy GP
Braz Oral Res; 2016 Aug; 30(1):e95. PubMed ID: 27556682
[TBL] [Abstract][Full Text] [Related]
53. Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.
Pignatelli J; Goswami S; Jones JG; Rohan TE; Pieri E; Chen X; Adler E; Cox D; Maleki S; Bresnick A; Gertler FB; Condeelis JS; Oktay MH
Sci Signal; 2014 Nov; 7(353):ra112. PubMed ID: 25429076
[TBL] [Abstract][Full Text] [Related]
54. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
Špirić Z; Eri Ž; Erić M
Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
[TBL] [Abstract][Full Text] [Related]
55. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
Huang R; Ding P; Yang F
Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
[TBL] [Abstract][Full Text] [Related]
57. Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer.
Oishi Y; Nagasaki K; Miyata S; Matsuura M; Nishimura SI; Akiyama F; Iwai T; Miki Y
J Hum Genet; 2007; 52(3):271-279. PubMed ID: 17285241
[TBL] [Abstract][Full Text] [Related]
58. Changes in the tumor microenvironment during lymphatic metastasis of lung squamous cell carcinoma.
Ikemura S; Aramaki N; Fujii S; Kirita K; Umemura S; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Kuwata T; Kojima M; Ochiai A; Betsuyaku T; Tsuboi M; Goto K; Ishii G
Cancer Sci; 2017 Jan; 108(1):136-142. PubMed ID: 27761967
[TBL] [Abstract][Full Text] [Related]
59. Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer.
Croizer H; Mhaidly R; Kieffer Y; Gentric G; Djerroudi L; Leclere R; Pelon F; Robley C; Bohec M; Meng A; Meseure D; Romano E; Baulande S; Peltier A; Vincent-Salomon A; Mechta-Grigoriou F
Nat Commun; 2024 Apr; 15(1):2806. PubMed ID: 38561380
[TBL] [Abstract][Full Text] [Related]
60. A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast.
Pal B; Chen Y; Vaillant F; Capaldo BD; Joyce R; Song X; Bryant VL; Penington JS; Di Stefano L; Tubau Ribera N; Wilcox S; Mann GB; ; Papenfuss AT; Lindeman GJ; Smyth GK; Visvader JE
EMBO J; 2021 Jun; 40(11):e107333. PubMed ID: 33950524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
